Drugs / AntiCD137
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00803374 | Nov 2010 → Jul 2012 | melanoma | Bristol-Myers Squibb | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AntiCD137 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00803374 ↗ |
| Route | Intravenous | “Infusion, IV” NCT00803374 ↗ |